AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer

Novotech to acquire Agilex Biolabs from Healius

ACROBiosystems launches CHO-Direct and ACRO AIx to accelerate AI-driven drug discovery

UChicago Medicine completes construction phase of new cancer facility

REGENXBIO reports positive three-year durability data for surabgene lomparvovec in diabetic retinopathy

Viking Therapeutics plans offerings of common stock and convertible senior notes

Astellas doses first patient in Phase 3 lung cancer study

AstraZeneca's Trixeo Aerosphere approved in EU for asthma maintenance treatment

Ondine Biomedical deployssteriwave across five Southern Ontario hospitals

Ionis reports positive Phase 3 sefaxersen data in IgA nephropathy

X-Chem and Relay Therapeutics collaborate on Phase 3 milestone

BoomRay enters exclusive radioligand therapy asset global license agreement with Novartis

AstronauTx receives funding to explore sleep-based approaches for Parkinson's disease

AbbVie secures EU approval for RINVOQ in polyarticular juvenile idiopathic arthritis

Genentech reports positive Phase II results for enicepatide in type 2 diabetes